Looking for some stimulating holiday reading over the holiday? I’m a big fan of Katherine Eban, an investigative journalist whose books read like thrillers. Her two highly regarded investigations detail pharmaceutical counterfeiting and fraud in the generic drug boom. She lectures frequently on the topic of pharmaceutical integrity. Eban’s newest book, reported over five years and on four continents, exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.
Dangerous Doses: A True Story of Cops, Counterfeiters, and the Contamination of America’s Drug Supply: Eban’s first book exposes the dark side of America’s pharmaceutical trade. Stolen, compromised, and counterfeit medicine increasingly makes its way into a poorly regulated distribution system—where it may reach unsuspecting patients who stake their lives on its effectiveness.
About LSPediA – Life Sciences Solutions
LSPediA is a leading supply chain software provider for the pharmaceutical industry. LSPediA’s serialization solution RxChain®, RxChain® Mobile, and our Verification Router Service protect pharma companies against regulatory risks and improve supply chain efficiency. Pharmaceutical manufacturers, wholesale distributors, dispensers, and healthcare providers partner with LSPediA to manage serial data, distribute serialized drug products, verify the validity of the drug product.